NUBEQA ,in combination with ADT is indicated for the treatment of adult men with non metastatic castration resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease NUBEQA is indicated for the treatment of adult patients with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with docetaxel